Understand the financial unit economics, break-even points, and gross margins of the Lumenis M22 by Lumenis.
The Lumenis M22 has a national average treatment price of $350 and consumable costs of $0 per session. Considering its capital cost of around $90,000, a clinic needs to perform roughly 258 treatments to break even.
$90,000
$350
$0
30 min
Positioned in the highly competitive Facial Rejuvenation category, the Lumenis M22 offers a steady value proposition. Stripping out the consumable cost of $0, each treatment yields roughly $350 in gross profit before factoring in staff hourly wages and baseline overhead.
At a fully financed capital burden of $90,000, you would need to sell approximately 258 individual treatments to break completely even. If your clinic processes 5 treatments per week, your break-even period would be roughly 12.9 months.
National averages hide local market realities. You must model the Lumenis M22 using your specific local lease rates, practitioner split (e.g., 20% provider commission), and aggressive financing interest rates.
Aesthetic Enterprises provides the business math. Our partner networks provide the clinical data, secondary market pricing, and financing.